CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net income (loss)	$ (254,553)	$ 73,109
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	10,323	5,132
Non-cash operating lease costs	10,873	8,699
Stock-based compensation, net of amounts capitalized	316,552	7,507
Amortization of deferred commissions	13,495	9,698
Net accretion of discounts on available-for-sale securities	(4,733)	(8,981)
Unrealized (gains) losses on equity investments, net	20,019	(13,855)
Remeasurement loss on digital assets, non-current	5,001	0
Other non-cash adjustments	1,802	1,343
Changes in assets and liabilities:
Accounts receivable, net	56,594	5,784
Prepaid expenses and other current assets	(17,398)	(2,871)
Other assets	(27,075)	(10,271)
Accounts payable	21,565	7,711
Accrued and other current liabilities	15,938	8,652
Accrued compensation and benefits	(43,635)	19,848
Deferred revenue	31,449	51,784
Other non-current liabilities	1,984	(3,657)
Net cash provided by operating activities	158,201	159,632
Cash flows from investing activities:
Purchase of intangible assets	(2,780)	0
Capital expenditures	(14,500)	(2,008)
Capitalized internal-use software development costs	(1,883)	(2,439)
Cash paid for business combinations, net of cash acquired	0	(21,004)
Purchases of marketable securities	(420,646)	(525,632)
Proceeds from maturities of marketable securities	345,173	475,836
Proceeds from sales of marketable securities	81,119	72,483
Purchase of digital assets	0	(30,000)
Other cash flows from investing activities	(183)	(811)
Net cash used in investing activities	(13,700)	(33,575)
Cash flows from financing activities:
Payment of deferred offering costs, net of costs reimbursed	0	(3,454)
Cash paid for issuance costs on revolving credit facility	0	(1,400)
Proceeds from options exercised	47,316	20,650
Proceeds from issuance of common stock under employee stock purchase plan	13,205	0
Taxes paid related to net share settlement of equity awards	(161,648)	0
Other cash flows from financing activities	(128)	(12)
Net cash provided by (used in) financing activities	(101,255)	15,784
Change in cash, cash equivalents, and restricted cash	43,246	141,841
Cash, cash equivalents, and restricted cash—beginning of period	413,191	490,585
Cash, cash equivalents, and restricted cash—end of period	456,437	632,426
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents	445,845	621,619
Restricted cash, included in prepaid expenses and other current assets	10,592	10,807
Total cash, cash equivalents and restricted cash	456,437	632,426
Cash paid during the period for income taxes, net of refunds
Federal	0	0
State	1,192	0
Foreign	2,063	0
Total cash paid during the period for income taxes, net of refunds	3,255	0
Cash paid during the period for income taxes (prior to ASU 2023-09)	0	6,440
Additional Cash Flow Elements
Payments for operating leases included in cash flows from operating activities	6,506	8,226
Right-of-use assets obtained in exchange for lease liabilities	12,671	42,007
Non-cash investing and financing activities:
Stock-based compensation included in capitalized internal-use software development costs	3,485	119
Unpaid deferred offering costs	$ 0	$ 3,555

Stock Issuance Costs Incurred But Not Yet Paid

No definition available.

Name:	fig_StockIssuanceCostsIncurredButNotYetPaid
Namespace Prefix:	fig_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.